|
|
|
|
||
BNVI 0.64Bionovo (BNVI) announced that enrollment has started for the Phase 1 clinical trial testing the safety of two doses of Menerba in postmenopausal women for the treatment of menopausal hot flushes (study # MF101-008). |
return to message board, top of board |